Intellia Therapeutics files initial beneficial ownership statement for EVP, Chief Medical Officer Jing L. Marantz
NTLA•Intellia Therapeutics filed an initial beneficial ownership statement for Jing L. Marantz, its executive vice president and chief medical officer.
1. Ownership filing
Intellia Therapeutics filed an initial beneficial ownership statement for Jing L. Marantz, executive vice president and chief medical officer.
